uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.
AngioGenetics Sweden AB och Karolinska Institutet, Institutionen för medicinsk biokemi och biofysik.
AngioGenetics Sweden AB och Karolinska Institutet, Institutionen för medicinsk biokemi och biofysik.
Show others and affiliations
2007 (English)In: Nature, ISSN 1476-4687, Vol. 445, no 7129, 776-80 p.Article in journal (Refereed) Published
Abstract [en]

In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A. VEGF-A is also essential for the induction of endothelial tip cells, but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4)-Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using gamma-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4-Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene, and indicates that modulators of Dll4 or Notch signalling, such as gamma-secretase inhibitors developed for Alzheimer's disease, might find usage as pharmacological regulators of angiogenesis.

Place, publisher, year, edition, pages
2007. Vol. 445, no 7129, 776-80 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-159702DOI: 10.1038/nature05571PubMedID: 17259973OAI: oai:DiVA.org:uu-159702DiVA: diva2:446361
Available from: 2011-10-07 Created: 2011-10-07 Last updated: 2011-10-07

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hellström, Mats
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 232 hits
ReferencesLink to record
Permanent link

Direct link